RVM
PFE icon

Robinson Value Management’s Pfizer PFE Stock Holding History

Robinson Value Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-6,534
Closed -$212K – 69
2017
Q1 		$212K Hold
6,534
– – 0.2% 63
2016
Q4 		$201K Buy
+6,534
New +$199K 0.19% 63

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Robinson Value Management's PFE Position: Q2 2017 in Review

Robinson Value Management sold out of Pfizer (PFE) in Q2 2017, closing a stake of 6,534 shares — an estimated $212K sold.

Robinson Value Management first reported a position in PFE in Q4 2016 and held it in 2 quarters. The position peaked at $212K in Q1 2017. 2,050 funds tracked by Wall St. Rank hold PFE as of Q2 2017.

  • Robinson Value Management reported no remaining Pfizer position as of Q2 2017 after selling out during the quarter.
  • Robinson Value Management sold 6,534 Pfizer shares in Q2 2017, an estimated $212K.
  • Robinson Value Management first reported a position in Pfizer in Q4 2016 and held it in 2 quarters.
  • Robinson Value Management's Pfizer position peaked at $212K in Q1 2017.
  • 2,050 funds tracked by Wall St. Rank held Pfizer as of Q2 2017.

Based on Robinson Value Management's 13F filing for Q2 2017, filed 7 Jul 2017.